Content
10/09/2024
San Carlos, CA USA
Arda Therapeutics
completed $43 million Series A Round funding. Investors include
Andreessen Horowitz (lead), Alumni Ventures, Biovision Ventures, Eli Lilly and Company, Exitfund, Gaingels, Google Ventures, Indicator Ventures, LifeLink Ventures, Mana Ventures, RV Invest, Two Sigma Ventures, Valhalla Partners.
About
Arda Therapeutics is pioneering the use of targeted cell depletion to treat chronic diseases. By identifying and selectively depleting pathogenic cells, Arda aims to develop therapies that offer greater efficacy, faster discovery timelines and reduced dosing frequency compared to traditional approaches. With a world-class team and a robust pipeline, Arda is poised to transform the landscape of chronic disease treatment.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
